Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010

Cancer

Volumn 121, Issue 1, 2015, Pages 102-112

  Gittleman, Haley R ^a,b   Ostrom, Quinn T ^a,b   Rouse, Chaturia D ^a   Dowling, Jacqueline A ^a   De Blank, Peter M ^a,c   Kruchko, Carol A ^b   Elder, J Bradley ^d   Rosenfeld, Steven S ^e   Selman, Warren R ^f   Sloan, Andrew E ^f   Barnholtz Sloan, Jill S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Brain Tumor Registry of the United States (CBTRUS)   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e TAUSSIG CANCER INSTITUTE   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Annual percent change (APC); Central Brain Tumor Registry of the United States (CBTRUS); Central nervous system tumors; Incidence rates; Time trends; United States Cancer Statistics (USCS)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; COLON CANCER; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PROSTATE CANCER; TREND STUDY; UNITED STATES; YOUNG ADULT; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLUSTER ANALYSIS; COHORT ANALYSIS; ETHNOLOGY; NEOPLASMS; PRESCHOOL CHILD; TIME;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SEER PROGRAM; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84918781973     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29015     Document Type: Article

References (28)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
2. Ward E, Esantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83-103.
3. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(suppl 2): ii1-ii56.
4. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975- 2010. Bethesda, MD: National Cancer Institute; 2013.
5. McCarthy BJ, Kruchko C, Dolecek TA. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends. J Registry Manag. 2013;40:32-35.
6. Centers for Disease Control and Prevention (CDC). United States Cancer Statistics: 1999-2010 Incidence, WONDER Online Database. wonder.cdc.gov/cancer-v2010.html. Accessed May 30, 2014.
7. National Cancer Institute. Joinpoint Regression Program, Version 4.1.0. Bethesda, MD: Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute; 2014.
8. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK. WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer; 2007.
9. Baan R, Grosse Y, Lauby-Secretan B, et al. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011;12:624-626.
10. Ostrom QT, Bauchet L, Davis F, et al. The epidemiology of glioma in adults: a "state of the science" review [published online ahead of print May 19, 2014]. Neuro Oncol.
11. Deltour I, Auvinen A, Feychting M, et al. Mobile phone use and incidence of glioma in the Nordic countries 1979-2008: consistency check. Epidemiology. 2012;23:301-307.
12. Little MP, Rajaraman P, Curtis RE, et al. Mobile phone use and gli-oma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ. 2012;344:e1147.
13. Barchana M, Margaliot M, Liphshitz I. Changes in brain glioma incidence and laterality correlates with use of mobile phones-a nationwide population based study in Israel. Asian Pac J Cancer Prev. 2012;13:5857-5863.
14. Dobes M, Khurana VG, Shadbolt B, et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): findings of a multicenter Australian study. Surg Neurol Int. 2011;2:176.
15. Baade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer. 2010;102: 620-626.
16. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:1961-1971.
17. McKean-Cowdin R, Razavi P, Barrington-Trimis J, et al. Trends in childhood brain tumor incidence, 1973-2009. J Neurooncol. 2013; 115:153-160.
18. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004;364:2097-2105.
19. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778-1786. http://www.ncbi.nlm.nih.gov/pubmed?term5 Independent%20UK%20Panel%20on%20Breast%20Cancer%20 Screening%5BCorporate%20Author%5D.
20. Brawley OW. Prostate cancer screening: biases and the need for consensus. J Natl Cancer Inst. 2013;105:1522-1524.
21. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409-418.
22. Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91:1382-1390.
23. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714-736.
24. McCarthy BJ, Propp JM, Davis FG, Burger PC. Time trends in oli-godendroglial and astrocytic tumor incidence. Neuroepidemiology. 2008;30:34-44.
25. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 1997;79:1381-1393.
26. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with ana-plastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473-1479.
27. Huse JT, Aldape KD. The molecular landscape of diffuse glioma and prospects for biomarker development. Expert Opin Med Diagn. 2013;7:573-587.
28. Weller M, van den Bent M, Hopkins K, et al; for the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of ana-plastic gliomas and glioblastoma. Lancet Oncol. 2014;15:e395-403.